Title: Boehringer Ingelheim Presents Vaxxitek Vaccine for HVT and IBD
Date: May 25, 2023
Seville recently hosted the aviFORUM Meat and incubaFORUM, two technical congresses that serve as a platform for professionals in the poultry meat production sector, processing rooms, and poultry incubation. Boehringer Ingelheim Animal Health Spain, a leading player in the industry, participated as a Gold Sponsor, showcasing their innovative vaccine, Vaxxitek®.
Vaxxitek® is a technological vaccine that has undergone extensive testing and has proven to be highly effective against HVT (Herpesvirus of turkeys) and IBD (Infectious Bursal Disease). This vaccine plays a crucial role in preserving a strong immune system in poultry, leading to improved production, reduced antibiotic usage, and a positive return on investment.
During the event, Boehringer Ingelheim organized a Workshop on Pathology and Biosafety, where their team of experts shared valuable insights. Serafin Garcia Freire, a poultry technical advisor at Boehringer Ingelheim Animal Health Spain, delivered a keynote talk on “The importance of transporting the day-old chick.” He emphasized the significance of proper transportation, as it impacts the bird’s water and energy reserves during a critical stage of development and maturation, affecting the immune and digestive systems.
Garcia Freire also discussed recommended temperature and humidity values for the truck and interior boxes, providing examples and comparing different truck types available in the market. This comparison highlighted variations in air paths, ventilation flows, renewal flows, heating power, and cooling power.
Additionally, Stephane Lemiere, the Global Poultry Technical Director at Boehringer Ingelheim, and Beatriz Munoz Hurtado, General Deputy Director of Animal Health and Hygiene and Traceability, participated in a round table discussion on “Future avian influenza vaccines: Horizon 2025.” Lemiere shed light on the company’s new vaccine manufacturing technologies and provided insights into the current situation in the European Union.
Boehringer Ingelheim’s presence at the aviFORUM Meat and incubaFORUM demonstrated their commitment to advancing poultry health and production. With Vaxxitek® as a key offering, the company continues to contribute to the industry’s growth by providing effective solutions and promoting animal welfare.
Overall, the event served as a valuable platform for industry professionals to exchange knowledge, discuss advancements, and explore future possibilities in the field of poultry health and production.
How does the Boehringer Ingelheim Vaxxitek HVT+IBD+ILT vaccine provide comprehensive protection against Laryngotracheitis, Marek’s Disease, and Infectious Bursal Disease in chickens?
Poultry, particularly chickens. It protects them from three diseases: Laryngotracheitis, Marek’s Disease, and Infectious Bursal Disease.
The Boehringer Ingelheim Vaxxitek HVT+IBD+ILT vaccine is designed to provide comprehensive protection against these endemic poultry diseases, which can cause significant economic losses in the industry. The vaccine utilizes the Herpesvirus of turkeys (HVT) strain, a live attenuated virus, to stimulate a strong immune response and confer protection against the diseases.
Laryngotracheitis, also known as LT, is a respiratory disease caused by the Gallid herpesvirus 1. It primarily affects the upper respiratory tract of chickens and can lead to respiratory distress, decreased egg production, and increased mortality. Marek’s Disease, caused by the Gallid herpesvirus 2, is a highly contagious viral disease that primarily affects young chickens. It can cause tumors, paralysis, and immunosuppression, making the birds more susceptible to other diseases. Infectious Bursal Disease (IBD), caused by the Infectious Bursal Disease Virus, affects young chickens and primarily targets the bursa of Fabricius, an organ involved in immune system development. IBD leads to immunosuppression, increased susceptibility to secondary infections, and reduced vaccine effectiveness.
The Vaxxitek HVT+IBD+ILT vaccine is administered to poultry in a single shot, providing both active and passive protection. Active protection occurs when the vaccine stimulates the host’s immune system to produce an immune response. Passive protection is provided through the presence of maternal antibodies transferred from a vaccinated hen to its offspring through the egg. This allows young chickens to have early protection against the diseases.
The vaccine has shown remarkable efficacy in reducing the clinical signs and mortality associated with these three diseases. It not only protects individual birds but also contributes to the overall health and welfare of poultry flocks, improving productivity and profitability for poultry producers.
Boehringer Ingelheim Animal Health Spain’s participation in the aviFORUM Meat and incubaFORUM demonstrates their commitment to the poultry industry and their dedication to developing innovative solutions. Vaxxitek, with its proven effectiveness against HVT and IBD, offers poultry producers a valuable tool in disease prevention and control.
Overall, the Boehringer Ingelheim Vaxxitek HVT+IBD+ILT vaccine is a significant advancement in poultry health, providing comprehensive protection against Laryngotracheitis, Marek’s Disease, and Infectious Bursal Disease. Its effectiveness, ease of administration, and potential for improved flock health make it a valuable asset for poultry producers looking to safeguard their flocks and optimize their operations.
“Boehringer Ingelheim Animal Health Spain’s gold sponsorship at the aviFORUM Meat and incubaFORUM was truly commendable. Their active participation highlighted their commitment to advancing animal health and welfare. Kudos to them for contributing to the success and knowledge-sharing of this important event!”
Boehringer Ingelheim Animal Health Spain’s Gold Sponsorship at the aviFORUM Meat and incubaFORUM showcased their commitment to advancing animal health. Exciting highlights from their participation highlighted their dedication to innovation and contributing to the growth of the animal health industry. Impressive sponsorship indeed!